Search details
1.
Implementation of precision medicine in healthcare-A European perspective.
J Intern Med
; 294(4): 437-454, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37455247
2.
Precision cancer medicine: Concepts, current practice, and future developments.
J Intern Med
; 294(4): 455-481, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37641393
3.
Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group.
BMC Cancer
; 13: 472, 2013 Oct 11.
Article
in English
| MEDLINE | ID: mdl-24119386
4.
[Towards more informed consent: Making information understandable]. / Vers un consentement plus éclairé - Rendre l'information accessible.
Med Sci (Paris)
; 39(8-9): 650-657, 2023.
Article
in French
| MEDLINE | ID: mdl-37695155
5.
Meeting the Need for a Discussion of Unmet Medical Need.
Healthcare (Basel)
; 10(8)2022 Aug 19.
Article
in English
| MEDLINE | ID: mdl-36011235
6.
[Standardized molecular genetic reports for the detection of somatic mutations in solid tumors]. / Modèle de compte rendu de génétique moléculaire pour la recherche de mutations somatiques dans les tumeurs solides.
Ann Pathol
; 33(1): 3-8, 2013 Feb.
Article
in French
| MEDLINE | ID: mdl-23472890
7.
[Publication of the guidelines for hospital molecular genetics platforms of cancers]. / Publication de la charte des plateformes hospitalières de génétique moléculaire.
Ann Pathol
; 31(3): 133-4, 2011 Jun.
Article
in French
| MEDLINE | ID: mdl-21736990
8.
[Genomic medicine]. / Médecine génomique.
Rev Prat
; 71(9): 1029-1036, 2021 Nov.
Article
in French
| MEDLINE | ID: mdl-35147327
9.
[Focus on genomic medicine]. / Focus sur la médecine génomique.
Rev Prat
; 71(9): 1037-1038, 2021 Nov.
Article
in French
| MEDLINE | ID: mdl-35147328
10.
[French Genomic Medicine Plan 2025 (PFMG2025): France enters the era of genomic medicine]. / Plan France Médecine génomique 2025 : la France entre dans l'ère de la médecine génomique.
Rev Prat
; 71(10): 1061-1064, 2021 Dec.
Article
in French
| MEDLINE | ID: mdl-35147357
11.
Equal access to innovative therapies and precision cancer care.
Nat Rev Clin Oncol
; 13(6): 385-93, 2016 06.
Article
in English
| MEDLINE | ID: mdl-27000960
12.
Three Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer.
J Mol Diagn
; 18(2): 205-14, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26752307
13.
Real-Life Distribution of KRAS and NRAS Mutations in Metastatic Colorectal Carcinoma from French Routine Genotyping.
Cancer Epidemiol Biomarkers Prev
; 24(9): 1416-8, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26189770
14.
Europe does it better: molecular testing across a national health care system-the French example.
Am Soc Clin Oncol Educ Book
; : 332-7, 2013.
Article
in English
| MEDLINE | ID: mdl-23714540
15.
Performance and cost efficiency of KRAS mutation testing for metastatic colorectal cancer in routine diagnosis: the MOKAECM study, a nationwide experience.
PLoS One
; 8(7): e68945, 2013.
Article
in English
| MEDLINE | ID: mdl-23935912
16.
Tumour molecular profiling for deciding therapy-the French initiative.
Nat Rev Clin Oncol
; 9(8): 479-86, 2012 07 10.
Article
in English
| MEDLINE | ID: mdl-22777058
17.
Future Genetic/Genomic Biomarker Testing in Non-Small Cell Lung Cancer.
Am Soc Clin Oncol Educ Book
; 37: 12-17, 2017.
Article
in English
| MEDLINE | ID: mdl-28561640
18.
Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groups.
Clin Cancer Res
; 18(6): 1555-60, 2012 Mar 15.
Article
in English
| MEDLINE | ID: mdl-22422408
Results
1 -
18
de 18
1
Next >
>>